ATP induces release of newly synthesized dopamine in the rat striatum.
Zhang
Y X
YX
Third Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
Yamashita
H
H
Ohshita
T
T
Sawamoto
N
N
Nakamura
S
S
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000502:physiology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D017551:Microdialysis; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology; D058919:Purinergic P2 Receptor Antagonists; D051381:Rats; D017208:Rats, Wistar; D012110:Reserpine / Q000494:pharmacology; D013498:Suramin / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology; D019805:alpha-Methyltyrosine; D020866:omega-Conotoxin GVIA
D002121:Calcium Channel Blockers; D015220:Calcium Channels; D008781:Methyltyrosines; D010455:Peptides; D058919:Purinergic P2 Receptor Antagonists; D014970:Xanthines; D015102:3,4-Dihydroxyphenylacetic Acid; D000249:Adenosine Monophosphate; D013779:Tetrodotoxin; D013498:Suramin; D000244:Adenosine Diphosphate; D019805:alpha-Methyltyrosine; D012110:Reserpine; D000255:Adenosine Triphosphate; D020866:omega-Conotoxin GVIA; C051869:8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine; D000241:Adenosine; D002118:Calcium; D004298:Dopamine; D006719:Homovanillic Acid